Here are 15 key notes on orthopedic and spine device companies over the past week.
Invibio signed a settlement agreement with the U.S. Federal Trade Commission to resolve antitrust allegations.
DJO Global reported 12.7 percent net sales growth to $278.9 million in the first quarter of 2016 over the same period last year.
GE Healthcare signed its first U.S. managed equipment services agreement.
Mazor Robotics generated revenues of $6.4 million for the first quarter of 2016, a 42 percent increase from the $4.5 million reported for the same period last year.
Misonix's global recurring revenue increased to $4 million in the third quarter of 2016, up from $3 million in the same period in fiscal 2015.
SI-BONE partnered with the Yale University Open Data Access Project to share data from the company's clinical trials.
DePuy Orthopaedics, part of the DePuy Synthes Companies of Johnson & Johnson, acquired BioMedical Enterprises.
The first surgeries using Safe Orthopaedics' new SteriSpineCC range have been successfully completed.
InVivo Therapeutics added Philadelphia-based University of Pennsylvania as a clinical site for the INSPIRE study.
OrthoPediatrics received regulatory clearance for its RESPONSE Spine System in Japan.
Camber Spine Technologies' ENZA Zero Profile Anterior Interbody Fusion system received FDA 510(k) clearance.
The FDA cleared the two-level components for Intelligent Implant Systems' Revolution Spinal System for sale in the United States.
France-based neurosurgeon Dr. Michael Lefranc performed the 100th procedure with the Medtech ROSA Spines robotic spine surgery device.
The first 10 procedures using Integra LifeSciences' Integra Cadence Total Ankle have been successfully completed.
RTI Surgical presented on why its stockholders should vote to elect the company's director nominees on the WHITE proxy card.